Continuing Education Videos

Welcome to the BCNA Continuing Education Video collection! Click any video below to add it to your personal collection. After watching a video, you will recieve a confirmation of credit hours earned. The videos are certified for continuing education in British Columbia; for other jurisdictions please contact us first.


Search by credit category:


Dr. Julie Durnan - Meet the Ginger Agency Webinar
Dr. Julie Durnan - Meet the Ginger Agency Webinar
0.75 hours Category C/D: General clinical education and/or professional development
Cost: Free for BCNA members or $30.00 for non-member customers

Dr. Julie Durnan - Meet the Ginger Agency Webinar

We are a team of highly experienced virtual administrative assistants who are fully vetted and specially trained to support Naturopathic Doctors, Wellness Practitioners, and their clients. Improve workflow, leverage your time, lower your overhead, and make significantly more money by integrating the Ginger Agency into your practice.
Click here for a downloadable PDF.

Dr. Judith Soon - Therapeutic Decision-making for contraception
Dr. Judith Soon - Therapeutic Decision-making for contraception
1.5 hours Category F: Pharmacotherapy
Cost: $45.00 for BCNA members or $135.00 for non-member customers

Dr. Judith Soon - Therapeutic Decision-making for contraception

Dr. Judith Soon discusses Therapeutic Decision-making for contraception

Dr. Jamison Falk - CVD Prevention followed by a review of Topical Analgesics
Dr. Jamison Falk - CVD Prevention followed by a review of Topical Analgesics
1.5 hours Category F: Pharmacotherapy
Cost: $45.00 for BCNA members or $135.00 for non-member customers

Dr. Jamison Falk - CVD Prevention followed by a review of Topical Analgesics

Dr. Jamison Falk discusses CVD Prevention followed by a review of Topical Analgesics.

NOTE: Two short segments of Jamison’s lecture have a technical glitch; sound and slides are fine, his face is frozen. 

The first is from approximately one hour and four minutes to one hour and twelve minutes, then again for the last minute. 

Dr. Doug Lobay - Rauwolfia in the Treatment of Hypertension
Dr. Doug Lobay - Rauwolfia in the Treatment of Hypertension
1.5 hours Category F: Pharmacotherapy
Cost: $45.00 for BCNA members or $135.00 for non-member customers

Dr. Doug Lobay - Rauwolfia in the Treatment of Hypertension

This seminar has been approved by CNPBC for 1.5 hours Category F (pharmacotherapy) continuing education.  The cost for BCNA members has been reduced 50%.

Dr. Aaron Hoo - Primary Care: Useful Tips & Prescribing Options for Common Conditions
Dr. Aaron Hoo - Primary Care: Useful Tips & Prescribing Options for Common Conditions
1 hour Category F: Pharmacotherapy
Cost: $30.00 for BCNA members or $90.00 for non-member customers

Dr. Aaron Hoo - Primary Care: Useful Tips & Prescribing Options for Common Conditions

This seminar has been approved by CNPBC for one-hour Category F (pharmacotherapy) continuing education.  The cost for BCNA members has been reduced 50%

ADDITIONAL NOTES:

 

Slide 7 - i believe i was discussing the Ciprodex formulation itself, containing ciprofloxacin & dexamethasone.  Below is the slide note...

Cefuroxime & Cefprozil – G2 cephalosporin (recall: G1 more coverage for Gm+ vs. G4 more coverage for Gm- organisms)

Amoxicillin covers a wide variety of gram-positive bacteria, with some added gram-negative coverage compared to penicillin. Similar to penicillin, it covers most Streptococcus species and has improved coverage of Listeria monocytogenes and Enterococcus. * Amoxicillin has narrow spectrum & is inexpensive

Amoxi-clav for resistant organisms; NB – increased pneumococcal & H. influenzae resistance makes Septra a less desirable agent

 

A topical fluoroquinolone/dexamethasone preparation (eg Ciprodex) is suggested for uncomplicated AOM with chronic TM perforation or ventilation tubes- presentation is that of painless d/c

Ciprodex has 3mg ciprofloxacin & 1mg dexamethasone per mL

 

Slide 18 - Ref:  Am Fam Physician. 2000 Aug 1;62(3):611-620    K.B Holten et. al

Beta-lactam antibiotics include penicillins, cephalosporins and related compounds. As a group, these drugs are active against many gram-positive, gram-negative and anaerobic organisms. Evidence in the literature supports the selection of amoxicillin as first-line antibiotic therapy for acute otitis media. Alternative drugs, such as amoxicillin-clavulanate, trimethoprim-sulfamethoxazole and cefuroxime axetil, can be used to treat resistant infections.

Penicillin V remains the drug of choice for the treatment of pharyngitis caused by group A streptococci. Inexpensive narrow-spectrum drugs such as amoxicillin or trimethoprim-sulfamethoxazole are first-line therapy for sinusitis. Animal and human bites can be treated most effectively with amoxicillin-clavulanate. For most outpatient procedures, amoxicillin is the preferred agent for bacterial endocarditis prophylaxis. Beta-lactam antibiotics are usually not the first choice for empiric outpatient treatment of community-acquired pneumonia.

 

Slide 27 - Ref: Guide to the Canadian Family Medicine Examination 2nd Ed. (A. Arnold & M. Dash); 2018 McGraw-Hill Publishers

 

Refer to MD if possible LuCA (constitutional sx eg. Unintended weight loss, night sweats, smoking hx); low-dose CT as a screening tool in those with >30pack year smoking history

Refer to MD for spirometry/pulmonary function testing to assess for possible COPD

 

https://canadiantaskforce.ca/guidelines/published-guidelines/lung-cancer/

Low dose computed tomography (LDCT)For adults aged 55-74 years with at least a 30 pack-year* smoking history who currently smoke or quit less than 15 years ago, we recommend annual screening with LDCT up to three consecutive times. Screening should ONLY be carried out in health care settings with expertise in early diagnosis and treatment of lung cancer.
Weak recommendation; low quality evidence.*pack-year defined as the (average number of cigarette packs smoked daily) x (number of years smoking)

For all other adults, regardless of age, smoking history or other risk factors, we recommend not screening for lung cancer with LDCT.
Strong recommendation; very low quality evidence

Chest x-ray (CXR)We recommend that chest x-ray not be used to screen for lung cancer, with or without sputum cytology.
Strong recommendation; low quality evidence.

 

The Pan Can Lung Cancer Risk Prediction Model is used to determine if a person should undergo annual computed tomography (CT) screening to detect early-stage lung cancer.

https://www.lungcancercanada.ca/Lung-Cancer/Screening.aspx

 

Slide 30: Ref: Guide to the Canadian Family Medicine Examination 2nd Ed. (A. Arnold & M. Dash); 2018 McGraw-Hill Publishers

 

Tool to help with possible need for hospital admission: The following tool estimates mortality for adults with CAP

PSI Score: Age, Gender, Nursing home resident, Neoplastic disease, LV disease history, CHF history, CVA history, Renal dz history, Altered mental status, RR >30, SBP <90, T <35 or >39.9, P >125 bpm, pH <7.35, BUN >30 mg/dL, Sodium < 130, Glucose >250 mg/dL, Hct <30%, PaO2 <60mmHg, pleural effusion on Xray

CRB 65: Confusion, RR >30, SBP < 90 or <60 DBP; Age >65 (score 1 for each): if score is >=3, admit urgently; if 2 require same day assessment in clinic , if 0-1 tx at home m/b appropriate

 

Amoxicillin 1g TID is active against 90-95% of S. pneumoniae and can be considered for patients > 50 yo. where Mycoplasma infection is less likely (Mandell 2007; Mills 2005)

 

Slide 51: Ref: Guide to the Canadian Family Medicine Examination 2nd Ed. (A. Arnold & M. Dash); 2018 McGraw-Hill Publishers

                        Anti-infective Guidelines for Community-acquired Infections; Anti-infective Review Panel 2013 ed. 

 

Recurrent vs Reinfection vs Relapse UTI

Recurrent: Two uncomplicated UTIs w/in 6 months OR three or more + urine cultures in the prior 12 months

Reinfection: occurs after 2 weeks of completing antimicrobial therapy; caused by different organism, most common

Relapse: Occurs w/in 2 weeks of completing antimicrobial treatment; caused by the original organism; bacteruria persists during tx or recurs after 1-2 weeks of finishing Abx tx; in minority of women (5-10%)

 

Dr. Julie Durnan - Pivoting to Telemedicine
Dr. Julie Durnan - Pivoting to Telemedicine
1 hour Category C/D: General clinical education and/or professional development
Cost: Free for BCNA members or $90.00 for non-member customers

Dr. Julie Durnan - Pivoting to Telemedicine

Dr. Julie Durnan discusses Pivoting to Telemedicine live from the BCNA office.

Nevin Fishman - Social Media Presence: Legal Pitfalls
Nevin Fishman - Social Media Presence: Legal Pitfalls
1 hour Category C/D: General clinical education and/or professional development
Cost: Free for BCNA members or $90.00 for non-member customers

Nevin Fishman - Social Media Presence: Legal Pitfalls

Free member webinar.

Hosted by Nevin Fishman, a Senior Partner at Branch McMaster with 30 years of experience in health law (including professional liability, administrative disputes, privileges and billing audits) and insurance litigation (including products’ liability, personal injury, CGL and disability).

Qualifies for one hour of Category C CE.

Telemedicine; Ensuring you are providing care responsibly and appropriately
Telemedicine; Ensuring you are providing care responsibly and appropriately
1 hour Category C/D: General clinical education and/or professional development
Cost: Free for BCNA members or $90.00 for non-member customers

Telemedicine; Ensuring you are providing care responsibly and appropriately

*There were technical difficulties with the audio at the start. The audio clears up within the first two minutes and the speaker repeats himself.

Free member webinar and live Q&A

Hosted by Nevin Fishman, a Senior Partner at Branch McMaster with 30 years of experience in health law (including professional liability, administrative disputes, privileges and billing audits) and insurance litigation (including products’ liability, personal injury, CGL and disability).

Qualifies for one hour of Category C CE.

Pharmacotherapy Q&A with Dr. Deborah Phair
Pharmacotherapy Q&A with Dr. Deborah Phair
1 hour Category F: Pharmacotherapy
Cost: Free for BCNA members or $90.00 for non-member customers

Pharmacotherapy Q&A with Dr. Deborah Phair

Pharmacotherapy Q&A with Dr. Deborah Phair joined by Dr. John Pidutti

Parenteral Therapies: Revisiting the Clinical Parameters for Safe, Effective Care
Parenteral Therapies: Revisiting the Clinical Parameters for Safe, Effective Care
2 hours Category F: Pharmacotherapy
Cost: $120.00 for BCNA members or $180.00 for non-member customers

Parenteral Therapies: Revisiting the Clinical Parameters for Safe, Effective Care

Dr. Paul Anderson, ND. In this session Dr. Anderson uses his many decades of injection experience to discuss customizing parenteral nutrient combinations and specific dosages for maximum efficacy. While this presentation covers the pharmacology and administration of vitamin, mineral and amino acids it also includes appropriate drug agents.
IV and IM administration are discussed and areas of augmentation effecting
adrenal, mitochondrial, neurological, immune and many other functional areas are also
discussed. Clinical comparisons of oral and injection therapies (and how to augment
therapies orally between injections) are provided. This session has ample
time for Q&A as well.

View the full Pharmacotherapy 2019 Syllabus

Pharmacy Concerns In Geriatrics
Pharmacy Concerns In Geriatrics
1.5 hours Category F: Pharmacotherapy
Cost: $90.00 for BCNA members or $135.00 for non-member customers

Pharmacy Concerns In Geriatrics

Dr. Alethea Fleming, ND. A commonly taught, but infrequently observed tenant of geriatric medicine is when a new problem arises first look to the patient’s medication list. Complications arise
with medications more readily in older patients. This lecture widely covers issues in
pharmacy with geriatric medicine using many clear case examples. We briefly
review essentials like how pharmacokinetics and pharmacodynamics change with
age and best tools to help decide how to change or stop medications (including
STOPP and START, Beer’s criteria, pharmacogenetic testing and clinical guidelines).
One primary component is on safe approaches to deprescribing including how to
initiate weaning medications, the importance of harm reduction, the role of OTC
medications, as well as how to best approach communication with patients, families,
and other health care providers. Special issues including changes in sleep with age
and common medication issues as well as the role of pharmacy in dementia are also
addressed. The goal of this presentation is to enable practitioners to feel more
confident in multiple aspects of pharmacy in geriatric care, especially deprescribing.

View the full Pharmacotherapy 2019 Syllabus

Travel Medicine: What you need to know
Travel Medicine: What you need to know
1.5 hours Category F: Pharmacotherapy
Cost: $90.00 for BCNA members or $135.00 for non-member customers

Travel Medicine: What you need to know

Ajit Johal, RPh, CTH, outlines the essential elements of a “pre-travel consultation” to help prepare patients traveling abroad by recommending appropriate immunizations, medications, and over the counter products, as well as providing them with travel advice and prevention strategies.

View the full Pharmacotherapy 2019 Syllabus

Bot Med & Pharma: Understanding the Indications, Contraindications and Drug Interactions with Botanical Medicines
Bot Med & Pharma: Understanding the Indications, Contraindications and Drug Interactions with Botanical Medicines
2 hours Category F: Pharmacotherapy
Cost: $120.00 for BCNA members or $180.00 for non-member customers
The Pharma of Contraception: Helping Your Patients Have a Good Sex Life Without Unwanted Pregnancies
The Pharma of Contraception: Helping Your Patients Have a Good Sex Life Without Unwanted Pregnancies
1.5 hours Category F: Pharmacotherapy
Cost: $90.00 for BCNA members or $135.00 for non-member customers
Antibiotics Review: What's Currently Being Prescribed, Why, Precautions and Considerations & Focus on Diabetes: Inhibitors, Agonists, and New Classes of Meds
Antibiotics Review: What's Currently Being Prescribed, Why, Precautions and Considerations & Focus on Diabetes: Inhibitors, Agonists, and New Classes of Meds
1.5 hours Category F: Pharmacotherapy
Cost: $90.00 for BCNA members or $135.00 for non-member customers
The Pharmacotherapy for Opioid Use Disorder & Incorporating Harm Reduction into Clinical Practice
The Pharmacotherapy for Opioid Use Disorder & Incorporating Harm Reduction into Clinical Practice
1.5 hours Category F: Pharmacotherapy
Cost: $90.00 for BCNA members or $135.00 for non-member customers
How to Present Medical Evidence to Patients (and Figure out if the Treatment you Recommended Actually Worked) & Reporting Lab Results: The Cause of, and the Solution to, the Over-diagnosis Problem
How to Present Medical Evidence to Patients (and Figure out if the Treatment you Recommended Actually Worked) & Reporting Lab Results: The Cause of, and the Solution to, the Over-diagnosis Problem
1.5 hours Category F: Pharmacotherapy
Cost: $90.00 for BCNA members or $135.00 for non-member customers
Thyroid Continued, Immune Dysfunction in Chronic Lyme Patients
Thyroid Continued, Immune Dysfunction in Chronic Lyme Patients
2 hours Category F: Pharmacotherapy
Cost: $120.00 for BCNA members or $180.00 for non-member customers

Thyroid Continued, Immune Dysfunction in Chronic Lyme Patients

NB: This video contains more information on the slides than is provided in the lecture.  Viewers may want to stop the webinar from time to time to take notes or screen captures.

This video falls into three different categories.

Part one, about 50 minutes, covers:

- Assessing hypothyroid: signs, symptoms, physical exam, BMR, reflex and important labs

- How to monitor and when to test

- Treatments associated with positive outcomes and dosage strategies

- Assessing hypothyroid: signs, symptoms, physical exam, BMR, reflex and important labs

- How to monitor and when to test

- Treatments associated with positive outcomes and dosage strategies

Part 2, around five minutes, covers:

- HPA axis dysfunction, adrenal function/dysfunction

- Holtorf answers a few thyroid questions

- Treating adrenal fatigue with cortisol dosages 

Part 3, around 15 minutes, he addresses:

- Lyme, Chronic Fatigue Syndrome, Fibromyalgia and myalgic encephalomyelitis

- Quick review on studies and information on CFS/FM and problems with them

- Infectious component of chronic diseases and how the TH1/TH2 arms of the immune system are affected

- Immune dysfunction in chronic disease

- Treatment plan ideas (but you will have to pause the video to read the slide, he buzzes through)

- Immunomodulating therapies (will need to pause)

- Labs and markers of immune dysfunction

 

Endocrinology in Chronic Illness
Endocrinology in Chronic Illness
2 hours Category F: Pharmacotherapy
Cost: $120.00 for BCNA members or $180.00 for non-member customers

Endocrinology in Chronic Illness

This video is roughly organized into a 1.5 hour lecture, a 15 minute Q&A followed by additional lecturing.

The original lecture addresses:

  • How hormones influence chronic disease and vice versa (and how restoring hormones helps chronic conditions)
  • Important lab tests, reference ranges and why these may not be reliable
  • Hormone formulations and how route changes efficacy and safety
  • A thorough review on the Women's Health Initiative Study and a review on why progesterone, estrogen and bioidentical hormone replacements are preferred (for their cardiovascular and cancer protective benefits)

Following the Q&A, the second portion of the lecture addresses:

  • Accuracy, importance and interpretation of thyroid tests (TSH, T3, T4, RT3)
  • Effects of chronic disease on thyroid hormone levels (obesity, fatigue, pain, mitochondrial dysfunction, depression/bipolar, chronic dieting, diabetes and cardiovascular disease)
The Ripple Effect of Polypharmacy In The Elderly - Keeping It Safe!
The Ripple Effect of Polypharmacy In The Elderly - Keeping It Safe!
1.5 hours Category F: Pharmacotherapy
Cost: $90.00 for BCNA members or $135.00 for non-member customers
Anticholinergic Medications and their Impact on Brain Function & Considerations in Commonly Prescribed Geriatric Meds
Anticholinergic Medications and their Impact on Brain Function & Considerations in Commonly Prescribed Geriatric Meds
1.5 hours Category F: Pharmacotherapy
Cost: $90.00 for BCNA members or $135.00 for non-member customers

Video added

This video has been added to your list of videos to purchase. To complete purchase, you will need to log in.

Click the "my videos" button at the bottom of this page at any time to proceed.